Otsuka Holdings Co., Ltd., announced that the changes of directors detailed below were determined today at a meeting of its Board of Directors.
The resolution is subject to approval at the annual general shareholders' meeting and Audit & Supervisory Board scheduled for March 29, 2018.
Changes of Director and Audit & Supervisory Board Member
Name
New Position (as of March 29, 2018)
Yuko Makino
Executive Director
Name
New Position (as of March 29, 2018)
Noriko Tojo
Executive Director
Name
New Position (as of March 29, 2018)
Kou Sekiguchi
Outside Director
Name
New Position (as of March 29, 2018)
Yozo Toba
Audit & Supervisory Board Member
Name
New Position (as of March 29, 2018)
Kazuo Takahashi
Outside Audit & Supervisory Board Member
Noriko Tojo will serve concurrently as President and Representative Director of Otsuka Medical Devices Co., Ltd.
-1-
Resignation of Director and Audit & Supervisory Board Member
Name
Current Position
Yasuyuki Hirotomi
Outside Director
Name
Current Position
Takaharu Imai
Standing Audit & Supervisory Board Member
Name
Current Position
Norikazu Yahagi
Outside Audit & Supervisory Board Member
Otsuka Foods Co., Ltd. determined the changes of directors detailed below at a meeting of its Board of Directors on February 9, 2018. The resolution is subject to approval at the annual general shareholders' meeting scheduled for March 9, 2018.
Name
Sadanobu Tobe
New Position
Chairman (Board Member),
Otsuka Foods Co., Ltd.
Previous Position
President and Representative Director,
Otsuka Foods Co., Ltd.
Effective Date
March 9, 2018
Name
Atsumasa Makise
New Position
President and Representative Director,
Otsuka Foods Co., Ltd.
Previous Position
Executive Director, Otsuka Foods Co., Ltd.
Effective Date
March 9, 2018
Sadanobu Tobe and Atsumasa Makise will serve concurrently as Director of Otsuka Holdings Co., Ltd.
- 2 -
Otsuka Holdings Co. Ltd. published this content on 14 February 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 14 February 2018 04:35:01 UTC.
Original documenthttps://www.otsuka.com/en/hd_release/release/pdf.php?news=1739
Public permalinkhttp://www.publicnow.com/view/607E380FC4F1F4E5AE372FDAE1ABD0550EE9A2D4
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
OTSUKA HOLDINGS CO., LTD. 
